연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3235. Comparative outcomes and prognostic indicators in adrenalectomy for adrenal metastasis
JungHak Kwak, Hye Lim Bae, Younghoon Jung, Jaebong Choi, Hyeonuk Hwang, Jung Hee Kim, Su-Jin Kim, Kyu Eun Lee
Surg Endosc. 2024 Apr;38(4):1884-1893.
Link
3234. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach
Hye Lim Bae, Junice Shi-Hui Wong, Su-Jin Kim, Younghoon Jung, Jae Bong Choi, JungHak Kwak, Hyeong Won Yu, Young Jun Chai, June Young Choi, Kyu Eun Lee
Sci Rep. 2024 May 21;14(1):11646.
Link
3233. Global prevalence of Mycobacterium massiliense strains with recombinant rpoB genes (Rec-Mas) horizontally transferred from Mycobacterium abscessus: two major types, dominant circulating clone 7 and MLST ST46 sequence type
Dong Hyun Kim 1 2, Hyejun Seo 1 3 4, Sangkwon Jung 3, Bum-Joon Kim 1 2 3 4 5
Microbiol Spectr. 2024 Oct 21;12(12):e0193524.
Link
3232. Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma
Dong Hyun Kim 1, Seo Yoon Jang 2, Bhumsuk Keam 3
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Dec;138(6):763-771.
Link
3231. Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Dong Hyun Kim 1, Seung Taek Lim 2, Hye Ryun Kim 3, Eun Joo Kang 4, Hee Kyung Ahn 5, Yun-Gyoo Lee 6, Der Sheng Sun 7, Jung Hye Kwon 8, Sang-Cheol Lee 9, Hyun Woo Lee 10, Min Kyoung Kim 11, Bhumsuk Keam 12, Keon-Uk Park 13, Seong-Hoon Shin 14, Hwan Jung Yun 15
Oral Oncol
. 2024 Apr:151:106739.
Link
3230. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment
Dong Hyun Kim 1 2, Jong Seok Ahn 3, Mingu Kang 3, Gahee Park 3, Yoojoo Lim 3, Soohyun Hwang 3, Chan-Young Ock 3, Jiwon Koh 4 5, Eun-Jae Chung 6, Seong-Keun Kwon 6, Yoon Kyung Jeon 4 5, Kyeong Cheon Jung 4, Soon-Hyun Ahn 6, Bhumsuk Keam 1 5
Cells. 2024 Sep 16;13(18):1557.
Link
3229. Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
Dong Hyun Kim 1 2, Mingu Kang 3, Gahee Park 3, Mohammad Mostafavi 3, Yoojoo Lim 3, Chan-Young Ock 3, Jiwon Koh 4 5, Yoon Kyung Jeon 4 5, Kyeong Cheon Jung 4, Soon-Hyun Ahn 6, Eun-Jae Chung 6, Seong-Keun Kwon 6, Bhumsuk Keam 7 8
Discov Oncol. 2024 Nov 20;15(1):686.
Link
3228. Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials
Youjin Kim 1, Bhumsuk Keam 2 3, Eun Joo Kang 4, Jin-Soo Kim 5, Hye Ryun Kim 6, Keun-Wook Lee 7, Jung Hye Kwon 8, Kyoung Eun Lee 9, Yaewon Yang 10, Yoon Hee Choi 11, Min Kyoung Kim 12, Jun Ho Ji 13, Tak Yun 14, Moon Young Choi 15, Ki Hyeong Lee 10, Sung-Bae Kim 16, Myung-Ju Ahn 17
Cancer Res Treat. 2024 Oct;56(4):1068-1076
Link
3227. Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer
Hanbaek Yi 1, Jeonghwan Youk 1 2, Yoojoo Lim 3, Hanseong Roh 3, Dongsoo Kyung 3, Hwang-Phill Kim 3, Duhee Bang 4, Bhumsuk Keam 1 2, Tae-Min Kim 1 2, Miso Kim 1 2, Dong-Wan Kim 1 2, Tae-You Kim 1 2 3
Cancer Res Treat. 2024 Jul;56(3):765-773
Link
3226. Measurement Variability of Same-Day CT Quantification of Interstitial Lung Disease: A Multicenter Prospective Study.
Lee JH, Chae KJ, Park J, Choi SM, Jang MJ, Hwang EJ, Jin GY, Goo JM.
Radiol Cardiothorac Imaging. 2024 Apr;6(2):e230287
Link